Literature DB >> 19539058

Critical timing, location and duration of glucocorticoid administration rescue mice from superantigen-induced shock and attenuate lung injury.

Teresa Krakauer1, Marilyn J Buckley, Louis M Huzella, Derron A Alves.   

Abstract

Bacterial superantigens, such as staphylococcal enterotoxin B (SEB), are major virulence factors implicated in the pathogenesis of toxic shock. In this study we investigated the efficacy of glucocorticoid therapy in preventing SEB-induced lethal shock initiated through the respiratory route in mice. Dexamethasone, a potent anti-inflammatory steroid, administrated intranasally on the first day, followed by intraperitoneal doses on the subsequent 4 days, was effective in attenuating SEB-induced hypothermia, and reduction in systemic and pulmonary proinflammatory mediator release. This optimal dosing and schedule of glucocorticoid treatment mitigated lung inflammation and resulted in 100% survival in this intranasal mouse model of SEB-mediated shock.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19539058     DOI: 10.1016/j.intimp.2009.06.004

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  12 in total

1.  CD1d-independent activation of invariant natural killer T cells by staphylococcal enterotoxin B through major histocompatibility complex class II/T cell receptor interaction results in acute lung injury.

Authors:  Sadiye Amcaoglu Rieder; Prakash Nagarkatti; Mitzi Nagarkatti
Journal:  Infect Immun       Date:  2011-05-31       Impact factor: 3.441

2.  Interference of the T Cell and Antigen-Presenting Cell Costimulatory Pathway Using CTLA4-Ig (Abatacept) Prevents Staphylococcal Enterotoxin B Pathology.

Authors:  Sarah J C Whitfield; Chris Taylor; Jane E Risdall; Gareth D Griffiths; James T A Jones; E Diane Williamson; Sjoerd Rijpkema; Luisa Saraiva; Sandrine Vessillier; A Christopher Green; Alun J Carter
Journal:  J Immunol       Date:  2017-03-20       Impact factor: 5.422

Review 3.  Drug repurposing for the treatment of staphylococcal infections.

Authors:  Shankar Thangamani; Haroon Mohammad; Waleed Younis; Mohamed N Seleem
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 4.  Therapeutic down-modulators of staphylococcal superantigen-induced inflammation and toxic shock.

Authors:  Teresa Krakauer
Journal:  Toxins (Basel)       Date:  2010-07-29       Impact factor: 4.546

Review 5.  The staphylococcal enterotoxin (SE) family: SEB and siblings.

Authors:  Teresa Krakauer; Bradley G Stiles
Journal:  Virulence       Date:  2013-04-19       Impact factor: 5.882

Review 6.  Staphylococcal Superantigens Spark Host-Mediated Danger Signals.

Authors:  Teresa Krakauer; Kisha Pradhan; Bradley G Stiles
Journal:  Front Immunol       Date:  2016-02-02       Impact factor: 7.561

Review 7.  PI3K/Akt/mTOR, a pathway less recognized for staphylococcal superantigen-induced toxicity.

Authors:  Teresa Krakauer
Journal:  Toxins (Basel)       Date:  2012-11-15       Impact factor: 4.546

Review 8.  Update on staphylococcal superantigen-induced signaling pathways and therapeutic interventions.

Authors:  Teresa Krakauer
Journal:  Toxins (Basel)       Date:  2013-09-24       Impact factor: 4.546

9.  Mesenchymal stromal (stem) cells suppress pro-inflammatory cytokine production but fail to improve survival in experimental staphylococcal toxic shock syndrome.

Authors:  Hani Kim; Ilyse Darwish; Maria-Fernanda Monroy; Darwin J Prockop; W Conrad Liles; Kevin C Kain
Journal:  BMC Immunol       Date:  2014-01-14       Impact factor: 3.615

10.  Late multiple organ surge in interferon-regulated target genes characterizes staphylococcal enterotoxin B lethality.

Authors:  Gabriela A Ferreyra; Jason M Elinoff; Cumhur Y Demirkale; Matthew F Starost; Marilyn Buckley; Peter J Munson; Teresa Krakauer; Robert L Danner
Journal:  PLoS One       Date:  2014-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.